1999 Porsche 911 Convertible With New Engine on 2040-cars

Auto blog

Porsche 911 RSR stops just long enough to have its photo taken

When it comes to Porsche and its rapidly escalating endurance racing program, all eyes may be on the new 919 Hybrid - and with good reason: that's the vehicle with which Porsche will be challenging the likes of Audi and Toyota for wins in the top-tier LMP1 class of the FIA World Endurance Championship and at Le Mans. But it's the 911 RSR that does and will continue to form the backbone of the factory's effort.
The 470-horsepower racing version of the road-going 911 took a one-two finish in its class at Le Mans last year, and also won its class at the Daytona 24 this past January as well. This year Porsche will field two of them in the WEC, another two in the United SportsCar Championship here in the US and will sell countless more to customer racing teams that will undoubtedly continue to rack up trophies in racing series around the world. This, then, might be a unique chance to see one standing still. Check it out in our gallery of live images above from the Geneva Motor Show.

Porsche Macan Turbo vs Cayman GTS in track battle

"Well this is stupid." On the surface, that was our reaction to this video, as well. Why would you compare the hottest Porsche Cayman with a crossover of any kind, even if it is the 400-horsepower Macan Turbo?
We're guessing because it'd be bloody good fun, as evidenced Auto Express's latest track battle. To be fair, there is some interesting stuff here. The two do have a similar starting price, separated by less than $3,000 here in the US market. And, factoring in the Macan's hefty horsepower and torque advantages - 60 horsepower and 126 pound-feet - does make for a slightly interesting comparison.
We won't spoil the verdict, so check out the full video from Auto Express, and then let us know what you think in Comments.

Porsche suspends ties with Maria Sharapova after drug test

Porsche has reportedly suspended ties with Maria Sharapova after the Russian tennis star failed a drug test. The German automaker stopped short of terminating its relationship with the athlete altogether as it awaits the results of a deeper investigation. The issue emerged at the Australian Open, where Sharapova reportedly tested positive for use of a drug called meldonium. Manufactured in Latvia and prescribed in many former Soviet Bloc countries, meldonium is used to treat heart conditions and improve cardiac circulation. It is not approved by the FDA for use in the United States, and the World Anti-Doping Agency added it to its list of prohibited substances at the start of this year. Sharapova admitted that she's been taking the medication for ten years now but that she did not keep up to date on the WADA's list. Since it is considered a prohibited substance, she's been excluded from participating in the Australian Open this year, and suspended from competition as of March 12. She was also scheduled to take part in the Porsche Grand Prix, a tennis event sponsored by the carmaker in Stuttgart next month which she will now apparently have to miss. One of the top-rated female tennis players in the world, Sharapova has served as a brand ambassador for Porsche since 2013. Other sponsors including TAG Heuer and Nike have also reportedly suspended their relationships with the athlete pending further investigation by the International Tennis Federation. Related Video: